Ambrosia adds continuous hormone insights to RIZZ for women

Ambrosia Systems says RIZZ will soon add continuous hormone intelligence for women, using glucose and longitudinal metabolic data to deliver personalized insights on estrogen, progesterone, cortisol and more. The feature is slated for rollout in the coming weeks and could expand later to men's health.

Why it matters: - Ambrosia Systems is pushing RIZZ beyond glucose tracking into hormone-aware wellness guidance. - The update targets a gap in women’s health: most people still rely on occasional lab tests or symptom logs to understand hormonal shifts. - The feature is designed to connect hormone patterns with metabolism, sleep, mood, recovery, fertility and menopause.

What happened: - Ambrosia Systems announced the upcoming availability of RIZZ Continuous Hormone Intelligence for Women on June 17, 2026. - The capability will provide personalized insights into estrogen, progesterone, cortisol, testosterone, LH, FSH, thyroid health, fertility, menopause and overall wellness. - The feature will be available at no additional cost to existing RIZZ users. - Ambrosia says the product will roll out in the coming weeks.

The details: - RIZZ Continuous Hormone Intelligence uses continuous glucose information and years of longitudinal metabolic data. - The system aims to deliver context-aware recommendations tailored to each person’s biology. - Example insights include luteal-phase shifts in insulin sensitivity, fasting glucose, heart rate variability and sleep quality. - Another example flags elevated stress-related cortisol activity and links prior improvements to sleep and avoiding late-night meals. - A third example suggests a user may be approaching ovulation and notes historically better insulin sensitivity and recovery in that phase. - Piyush Gupta, founder and CEO of Ambrosia Systems, said hormone understanding has traditionally been limited to occasional snapshots and that RIZZ is another step toward continuous, personalized and proactive health. - Ambrosia says the new capability will continue to evolve as more data and insights become available.

Between the lines: - The launch reflects a broader move in digital health toward continuous monitoring instead of point-in-time testing. - Ambrosia is positioning metabolic data as a way to infer hormonal patterns without requiring frequent lab work. - The planned men's health expansion suggests the company sees hormone intelligence as a broader platform, not a women-only feature.

What's next: - The women’s hormone intelligence features are expected to become available to RIZZ users in the coming weeks. - Future updates are expected to expand into men's health with insights into testosterone, cortisol, thyroid health, stress, recovery, metabolism, fertility and healthy aging. - Ambrosia says the product will keep improving as additional data becomes available. - RIZZ Continuous Hormone Intelligence is intended for general wellness only and is not meant to diagnose, treat, cure or prevent disease.